Exelixis
EXEL
#1704
Rank
HK$76.11 B
Marketcap
HK$266.52
Share price
0.50%
Change (1 day)
62.18%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: HK$76.11 Billion

As of November 2024 Exelixis has a market cap of HK$76.11 Billion. This makes Exelixis the world's 1704th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$76.11 B30.63%
2023HK$58.26 B44.13%
2022HK$40.42 B-10.36%
2021HK$45.09 B-6.57%
2020HK$48.26 B15.77%
2019HK$41.69 B-9.73%
2018HK$46.19 B-34.27%
2017HK$70.26 B109.63%
2016HK$33.52 B236.39%
2015HK$9.96 B355.44%
2014HK$2.18 B-75.06%
2013HK$8.77 B34.8%
2012HK$6.50 B30.52%
2011HK$4.98 B-28.6%
2010HK$6.98 B13.23%
2009HK$6.16 B50.55%
2008HK$4.09 B-41.88%
2007HK$7.04 B4.9%
2006HK$6.71 B10.3%
2005HK$6.09 B10.02%
2004HK$5.53 B42.11%
2003HK$3.89 B5.15%
2002HK$3.70 B-49.08%
2001HK$7.27 B36.51%
2000HK$5.33 B

End of Day market cap according to different sources

On Nov 3rd, 2024 the market cap of Exelixis was reported to be:

HK$75.73 Billion
by Yahoo Finance info icon info icon
HK$75.73 Billion
by CompaniesMarketCap info icon info icon
HK$75.73 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$586.26 B 670.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$1.040 T 1,266.93%๐Ÿ‡ซ๐Ÿ‡ท France
HK$2.007 T 2,536.93%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$874.12 B 1,048.46%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.324 T 1,639.59%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.961 T 3,790.54%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.222 T 1,506.41%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.20 B-99.74%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$4.05 B-94.68%๐Ÿ‡บ๐Ÿ‡ธ USA